Nottingham, United Kingdom

Stephen Yan Tat Chan



Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2017-2020

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Inventor Spotlight: Stephen Yan Tat Chan

Introduction

Stephen Yan Tat Chan, an innovative inventor based in Nottingham, GB, is making significant strides in the field of cancer research with two notable patents to his name. His work is contributing to a new era of personalized medicine, aimed at improving treatment outcomes for cancer patients.

Latest Patents

Chan's latest patents reflect his commitment to enhancing cancer therapy. The first patent, concerning the Biomarker SPAG5, introduces a method for determining the prognosis and suitable treatment for cancer patients by measuring SPAG5 expression levels. This innovative approach highlights the correlation between high SPAG5 expression in tumor cells and the presence of aggressive tumors, paving the way for more tailored treatment strategies.

The second patent focuses on a Breast Cancer Assay, detailing a method for screening breast cancer by assessing the Helicase Antigen (HAGE) levels in breast tissue samples. This method is instrumental in identifying samples that may respond favorably to chemotherapy, particularly in HAGE+ estrogen receptor-negative cancers. In addition, it outlines methods for treating breast cancers using HAGE-specific Cancer Test Antigens or HAGE-specific antibodies.

Career Highlights

Throughout his career, Stephen Chan has been associated with esteemed institutions such as Nottingham Trent University and Nottingham University Hospitals NHS Trust. His work at these organizations has significantly influenced cancer research and therapeutic methods.

Collaborations

Chan has collaborated with several notable professionals, including Graham Roy Ball and Tarek Mohamed Ahmed Abdel-Fatah. These partnerships have fostered a collaborative environment that supports the advancement of cancer treatment technologies.

Conclusion

Stephen Yan Tat Chan stands out as a remarkable inventor working at the intersection of technology and medicine. His innovative patents on cancer biomarkers and assays are a testament to his dedication to improving patient care through personalized therapies. As the landscape of cancer treatment continues to evolve, Chan's contributions will undoubtedly play a pivotal role in shaping future innovations in this critical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…